Site Search

Comprehensive panels - Insights

Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.

Single-gene assays - Insights

Find out how patients with a cancer diagnosis can benefit from single-gene analysis to pinpoint whether the cancer is genetic in nature.

Next-generation sequencing: Examining an often oversimplified & misunderstood technology--Part I

In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.

Sarcoma Pathology Consultation - Mayo Clinic Laboratories

For cases needing an added level of support, our second-opinion pathology consultations are conducted by a team of pathologists who are experts in bone and soft tissue pathology.

Single Gene Sarcoma Testing - Mayo Clinic Laboratories

In cases where comprehensive NGS analysis cannot be performed or the diagnosis is highly suspect, we also offer a variety of single-gene fluorescence in situ hybridization (FISH) tests

Focused lung panel informs the use of targeted cancer therapies - Insights

Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.

Lung Cancer PDL1 Testing - Mayo Clinic Laboratories

Mayo Clinic Laboratories offers three PD-L1 clones for assessing patient response to specific therapies.

5 Tips for Effectively Surveying Lab Customers - Insights

Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.

How Pathologists Support Successful Laboratory Outreach - Insights

A pathologist’s collaboration with the outreach team and referring physicians strengthens the program and provides the best service for patients.

Autoimmune Movement Disorders - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D. - Insights

Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...

Vision loss - Insights

See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.

Autoimmune Myelopathy Testing - Mayo Clinic Laboratories

Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis.

Autoimmune Dementia Testing - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.

The Power of Discovery: Mayo Clinic Laboratories Autoimmune Neurology Service - Insights

Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an...

Autoimmune testing education - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...

Neurofilament light chain: Bjorn Oskarsson, M.D. - Insights

In this test-specific episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Bjorn Oskarsson, M.D., a neurologist at Mayo Clinic’s Florida campus, discuss...

Hereditary Alzheimer's disease and dementia - Insights

Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.

FISH Testing - Insights

See how our comprehensive fluorescence in situ hybridization panels simplify the ordering process to ensure every patient receives the right test.

Diagnostic expertise leads to recovery from rare cancer: Alison O'Neill - Insights

After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the...

An emotional proposition for a pancreatic cancer survivor: Jim Smith - Insights

Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully,...

Staying the course through follow-up care and therapeutic drug monitoring: Billy Dowell Jr. - Insights

For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted...

Sickle cell disease: How new technologies are transforming patient lives - Insights

PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.

MCL @Work: Robin Huiras-Carlson - Insights

Robin Huiras-Carlson's connection with Mayo Clinic traces back to her early years, marked by a diagnosis of a rare genetic condition at the age of 10. Today, as a senior marketing specialist with Mayo Clinic Laboratories, she draws...

Mayo Clinic Labs @Work: Carrie Lahner - Insights

Carrie began her career at Mayo Clinic in 2006 as the associate director of the Eisenberg Genomics Education Program. In her current role as a genetic counselor, she employs her skills to educate on genetic test offerings and support MCL’s...

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC - Insights

Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for...

Northeast winter storm - Insights

A winter storm is occurring in the Northeast which may impact specimen transport. The winter storm is expected to spread snow, strong winds, and create possible blizzard conditions which could impact courier pickups and route delays. We are...

New Years Holiday Shipment Schedules - Insights

The United States will observe the New Year holiday on Monday, Jan. 1. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...

Monitoring Hurricane Debby - Insights

As Hurricane Debby moves through the Southeast United States (Florida, Georgia, South Carolina, North Carolina, and Virginia), we continue to monitor and track the situation with our logistics partners to minimize challenges. Clients in the...

Monitoring Tropical Storm Francine - Insights

Tropical Storm Francine is active in the Gulf of Mexico and is expected to develop into a hurricane. These weather conditions may impact areas in the United States, including Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and Texas....

Improvements to downtime process, form provide clarity for clients - Insights

The downtime process and form have been improved to provide clear guidance on the steps clients should take during downtime.

Monitoring Tropical Storm Helene - Insights

Tropical Storm Helene is approaching the Florida Gulf Coast and is expected to become a hurricane. These weather conditions may impact areas in the United States, including Alabama, Florida, Georgia, and South Carolina. We continue to...

Memorial Day 2024 Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming Memorial Day holiday on Monday, May 27, 2024. To ensure specimen stability and prevent delays, follow the guidelines below outlined for...

Specimen delays - Insights

Due to a major weather impact at the FedEx hub in Memphis, Tennessee, the Mayo Clinic Laboratories’ Global Logistics team is working to minimize any client impacts. Please visit our website for updates. For any immediate needs, please...

Winter Storm Finn: Potential specimen delays - Insights

There is a major weather system moving across the United States that may impact specimen transport. Winter storm Finn is expected to spread snow, strong winds, and create possible blizzard conditions into the Plains and Midwest. This may...

Dr. Morice Shares Trends and Predictions for 2025 - Insights

The healthcare and diagnostics landscape is poised for transformative changes driven by technological advancements and evolving market dynamics.

Mayo Clinic Discovers Gene Mutations Linked to Pancreatic Cancer, Calls for Expanded Testing - Insights

According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.

Urinary Steroid Profile [Test in Focus] - Insights

Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken...

Hepatocellular Carcinoma Risk Panel with GALAD Score - Insights

In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score...

Mayo Clinic Laboratory and Pathology Research Roundup: June 25 - Insights

This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.

Pathways Case Studies: September 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for September include the following sub-specialties: Cardiovascular Pathology,...

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...

Pathways Case Studies: December 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Cardiovascular Pathology and...

Pathways Case Studies: November 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cardiovascular Pathology,...

December 2023 - Cardiovascular and Infectious Diseases - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cardiovascular Pathology and Infectious Diseases Pathology.

September 2023 - Cardiovascular Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.

November 2023 - Cardiovascular Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.

Cardiovascular Pathology Services at Mayo Clinic Laboratories

Cardiovascular pathology focuses on a multidisciplinary approach to the consultative practice. Learn more about our service.

Ceramides - Insights

Ceramides are lipids associated with atherosclerotic plaque formation, hypertension, insulin resistance, and obesity. Mayo Clinic Laboratories’ testing quantifies ceramides, providing an early indicator to help physicians predict heart...

William Morice, II, M.D., discusses need for reform to the Protecting Access to Medicare Act of 2014 - Insights

Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt...